NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack tested for Tough-to-Treat lung cancer
Disease control TerminatedThis study tested whether adding a single, precise dose of radiation to an immunotherapy drug (atezolizumab) could help control advanced lung cancer that had started to grow again after initial chemotherapy and immunotherapy. It involved 12 adults with stage IV non-small cell lun…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New targeted drug tested for Tough-to-Treat lung cancers
Disease control TerminatedThis study tested a new type of targeted cancer drug called MYTX-011 in people with advanced non-small cell lung cancer (NSCLC) that had progressed after standard treatments. The main goals were to find a safe dose and see if the drug could shrink tumors, especially in patients w…
Matched conditions: NSCLC STAGE IV
Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC